Skip to main content

Camp4 Therapeutics Corp

CAMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001736730

In the last 90 days, Camp4 Therapeutics Corp insiders filed 5 open-market purchases and 4 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $182.2M in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Camp4 Therapeutics Corp as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
29
0 vs. Q2 2025
Shares held
28.2M
+16.5M (+140.2%) vs. Q2 2025
Total value
$84.6M
+$67.6M (+396.9%) vs. Q2 2025
New holders
8
4 more added
Sold out
8
10 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CAMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 29 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 36 institutionsQ1 2025: 39 institutionsQ2 2025: 29 institutionsQ3 2025: 29 institutionsQ4 2025: 40 institutionsQ1 2026: 46 institutionsQ2 2026: 61 institutions
Value heldQ3 2025: $84.6M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $67.1MQ1 2025: $50.7MQ2 2025: $17.0MQ3 2025: $84.6MQ4 2025: $234.6MQ1 2026: $175.5MQ2 2026: $182.2M
Institutions holding CAMP and their total value by quarter
QuarterHoldersValue
Q2 202661$182.2M
Q1 202646$175.5M
Q4 202540$234.6M
Q3 202529$84.6M
Q2 202529$17.0M
Q1 202539$50.7M
Q4 202436$67.1M
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Camp4 Therapeutics Corp; share changes are against Q2 2025.

Institutions holding CAMP in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
5AM Venture Management, LLC5,869,091$17.6M6.45%+2,941,176+100.5%Added
Janus Henderson Group PLC4,640,970$13.9M0.01%+4,640,970New
Vivo Capital, LLC3,921,568$11.8M0.95%+3,921,568New
Enavate Sciences GP, LLC3,785,802$11.4M3.47%00.0%Unchanged
FMR LLC3,023,434$9.07M0.00%+2,415,488+397.3%Added
AH Capital Management, L.L.C.2,125,339$6.38M0.46%00.0%Unchanged
Adage Capital Partners GP, L.L.C.1,960,784$5.88M0.01%+1,960,784New
HarbourVest Partners LLC1,271,948$3.82M1.86%00.0%Unchanged
Silverarc Capital Management, LLC653,594$1.96M0.28%+653,594New
Vanguard Group Inc313,506$940.5K0.00%−15,385−4.7%Reduced
Alyeska Investment Group, L.P.200,000$600.0K0.00%00.0%Unchanged
Two Sigma Investments, LP97,371$292.1K0.00%+97,371New
Millennium Management LLC95,071$285.2K0.00%−37,965−28.5%Reduced
Victory Capital Management Inc82,790$248.4K0.00%−270−0.3%Reduced
Geode Capital Management, LLC60,371$181.1K0.00%−14,828−19.7%Reduced
State Street Corp26,000$78.0K0.00%+26,000New
Bridgeway Capital Management, LLC25,000$75.0K0.00%00.0%Unchanged
Mariner, LLC17,298$51.9K0.00%+17,298New
Northern Trust Corp14,615$43.8K0.00%00.0%Unchanged
BlackRock, Inc.11,437$34.3K0.00%−72,784−86.4%Reduced
UBS Group AG7,043$21.1K0.00%+1,955+38.4%Added
Tower Research Capital LLC (TRC)5,649$16.9K0.00%+1,819+47.5%Added
Royal Bank of Canada953$3.00K0.00%00.0%Unchanged
Bank of America Corp283$8490.00%−369−56.6%Reduced
BNP Paribas Arbitrage, SA78$2340.00%−349−81.7%Reduced
Barclays PLC70$2100.00%+70New
SBI Securities Co., Ltd.15$450.00%−5−25.0%Reduced
Morgan Stanley3$90.00%−1,684−99.8%Reduced
CWM, LLC5$00.00%−63−92.6%Reduced
Goldman Sachs Group Inc0$00.00%−26,511−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−14,871−100.0%Sold out
Verition Fund Management LLC0$00.00%−14,760−100.0%Sold out
Cantor Fitzgerald, L. P.0$00.00%−12,320−100.0%Sold out
JPMorgan Chase & Co0$00.00%−238−100.0%Sold out
Wells Fargo & Company0$00.00%−119−100.0%Sold out
Nisa Investment Advisors, LLC0$00.00%−101−100.0%Sold out
EverSource Wealth Advisors, LLC0$00.00%−3−100.0%Sold out